Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 238

Similar articles for PubMed (Select 11157423)

1.

Therapeutic aspects of cannabis and cannabinoids.

Robson P.

Br J Psychiatry. 2001 Feb;178:107-15. Review.

2.

Cannabinoids fail to show evidence of slowing down the progression of multiple sclerosis.

Pryce G, Baker D.

Evid Based Med. 2015 Apr 20. pii: ebmed-2015-110198. doi: 10.1136/ebmed-2015-110198. [Epub ahead of print] No abstract available.

PMID:
25895527
3.

[Cannabis in multiple sclerosis treatment: possibilities and limits].

Vaney C.

Rev Med Suisse. 2015 Jan 28;11(459):312-4. Review. French. No abstract available.

PMID:
25845191
4.

Re-branding cannabis: the next generation of chronic pain medicine?

Carter GT, Javaher SP, Nguyen MH, Garret S, Carlini BH.

Pain Manag. 2015 Jan;5(1):13-21. doi: 10.2217/pmt.14.49.

PMID:
25537695
5.

Therapeutic potential of cannabinoids in counteracting chemotherapy-induced adverse effects: an exploratory review.

Ostadhadi S, Rahmatollahi M, Dehpour AR, Rahimian R.

Phytother Res. 2015 Mar;29(3):332-8. doi: 10.1002/ptr.5265. Epub 2014 Dec 12.

PMID:
25504799
6.

Cannabinoids: new promising agents in the treatment of neurological diseases.

Giacoppo S, Mandolino G, Galuppo M, Bramanti P, Mazzon E.

Molecules. 2014 Nov 17;19(11):18781-816. doi: 10.3390/molecules191118781.

7.

Cannabis for intractable nausea after bilateral cerebellar stroke.

Adhiyaman V, Arshad S.

J Am Geriatr Soc. 2014 Jun;62(6):1199. doi: 10.1111/jgs.12856. No abstract available.

PMID:
24925562
8.

Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.

Brunt TM, van Genugten M, Höner-Snoeken K, van de Velde MJ, Niesink RJ.

J Clin Psychopharmacol. 2014 Jun;34(3):344-9. doi: 10.1097/JCP.0000000000000129.

PMID:
24747979
9.

Sudden unexpected death under acute influence of cannabis.

Hartung B, Kauferstein S, Ritz-Timme S, Daldrup T.

Forensic Sci Int. 2014 Apr;237:e11-3. doi: 10.1016/j.forsciint.2014.02.001. Epub 2014 Feb 12.

PMID:
24598271
10.

Medicinal use of cannabis and cannabinoids in older adults: where is the evidence?

Ahmed AI, van den Elsen GA, van der Marck MA, Olde Rikkert MG.

J Am Geriatr Soc. 2014 Feb;62(2):410-1. doi: 10.1111/jgs.12661. No abstract available.

PMID:
24521388
11.

Therapeutic potential of cannabinoid medicines.

Robson PJ.

Drug Test Anal. 2014 Jan-Feb;6(1-2):24-30. doi: 10.1002/dta.1529. Epub 2013 Sep 4. Review.

PMID:
24006213
12.
13.

Medicinal cannabis and painful sensory neuropathy.

Grant I.

Virtual Mentor. 2013 May 1;15(5):466-9. doi: 10.1001/virtualmentor.2013.15.5.oped1-1305. No abstract available.

14.

Slim evidence for cannabinoids for epilepsy.

Miller JW.

Epilepsy Curr. 2013 Mar;13(2):81-2. doi: 10.5698/1535-7597-13.2.81. No abstract available.

15.

[Cannabis as a medicine": necessary and long overdue?].

Göbel H.

Schmerz. 2004 Dec;18 Suppl 2:S2-3. German. No abstract available.

PMID:
23570081
16.

Cannabis therapy.

Kowalski JT.

Dtsch Arztebl Int. 2013 Mar;110(9):144. doi: 10.3238/arztebl.2013.0144b. Epub 2013 Mar 1. No abstract available.

17.

Cannabis therapy.

Müller-Vahl K, Grotenhermen F.

Dtsch Arztebl Int. 2013 Mar;110(9):144. doi: 10.3238/arztebl.2013.0144a. Epub 2013 Mar 1. No abstract available.

18.

In reply.

Müller-Vahl K.

Dtsch Arztebl Int. 2013 Mar;110(10):175. doi: 10.3238/arztebl.2013.0175. Epub 2013 Mar 8. No abstract available.

19.

Limited range of indications for cannabis.

Wörz R.

Dtsch Arztebl Int. 2013 Mar;110(10):174. doi: 10.3238/arztebl.2013.0174b. Epub 2013 Mar 8. No abstract available.

20.

Scientific data are lacking.

Hagmann SG.

Dtsch Arztebl Int. 2013 Mar;110(10):174. doi: 10.3238/arztebl.2013.0174a. Epub 2013 Mar 8. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk